Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded UI elements and metadata: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed the older items Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision history updated: added v3.3.4 and removed v3.3.3.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded registry identifiers U1111-1282-1555 and 2022-501817-29-00. Replaced old EngageZone data-sharing references with trialstransparency.msdclinicaltrials.com and externaldatasharing-msd.com.SummaryDifference0.2%

- Check53 days agoChange DetectedThe Locations section now includes a large expansion of study sites across multiple countries and regions, listing new sites in the US, Canada, Europe, Asia, Australia, and South America. Several previously listed sites have been removed.SummaryDifference4%

- Check74 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; this maintenance update does not affect the study details, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.